CD8A and neoplasm: In conclusion, ANGPTL2 reduces tumor cell susceptibility to CD8+ T‐cell‐mediated anti‐tumor immune responses by promoting PRC2‐mediated repression of MHC‐I expression in tumor cells, thereby accelerating tumor progression.